2017 Newswire Archive


UoB publishes the results from a study commissioned to Neuregenix under the 2016 MRC CiC award to Ann Logan where they showed efficacy of an eye drop formulation of anti-VEGF drugs to topically to treat AMD

Neuregenix successfully completes a long series of studies for AbbVie evaluating the efficacy of novel therapeutic monoclonal antibodies for neurological conditions.


Tikomed signs new collaboration agreements with University of Birmingham and Neuregenix to carry out a pipeline of pre-clinical and clinical trials of ILB for ocular and neurodegenerative conditions.

website by whitespace